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Abstract 
 
Quinolone antibacterial agents represent a chemically homogenous group 
of purely synthetic antibiotics which originated in the early 1960s and still play an 
important role in the antimicrobial chemotherapy.  
Quinolones (or more specific, fluoroquinolones) are frequently used in 
human therapy for treatment of both common and serious diseases (they are 
irreplaceable also against bioterrorist weapons, such as anthrax). Some of the 
fluoroquinolones are also among the most used veterinary antimicrobials, 
including their large-scale usage in aquaculture. Only in the Czech Republic, their 
annual consumption is in the order of millions of defined daily doses (DDD). 
Fluoroquinolones as entirely synthetic compounds do not have any natural 
source in the environment – therefore their occurrence in both terrestrial and 
aquatic ecosystems is the result of human activity. Excluding the direct 
application to the aquatic environment (prophylaxis and treatment of bacterial 
diseases in the aquaculture), the most common point of entry of fluoroquinolones 
into the environment is via the wastewaters. Numerous studies carried out in 
different countries have shown that even after several steps of wastewater 
cleaning process, fluoroquinolones can be found in the final effluent of the 
wastewater treatment plants (the amounts of fluoroquinolones are mostly in the 
order of tens or hundreds of ng L-1). The effects of fluoroquinolones on the 
aquatic ecosystem are not known enough. 
In this study, I performed an ecotoxicological screening of three 
fluoroquinolone antibiotics (ciprofloxacin, norfloxacin, and ofloxacin, that are 
most commonly used in the Czech Republic) on four freshwater organisms in 
order to determinate acute toxicity of the tested chemotherapeutical agents. The 
experimental organisms included a green algal species, Pseudokirchneriella 
subcapitata, a ciliated protozoan, Tetrahymena pyriformis, a rotifer, Brachionus 
calyciflorus, and an anostracan crustacean, Thamnocephalus platyurus. All tests 
were conducted as acute toxicity tests. The concentrations of fluoroquinolones 
started at 12 mg L-1, 3 mg L-1, and 0.3 mg L-1, respectively and in each test at least 
eight different concentrations of the antibiotics were investigated. 
The results suggest that the acute toxicity of the three fluoroquinolones is 
considerably different to various species. The fluoroquinolones exhibited low 
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acute toxicity on algal species P. subcapitata and crustacean T. platyurus. 
Significantly higher acute toxicity of the quinolone antibiotics was observed on 
B. calyciflorus (with the exception of norfloxacin) and T. pyriformis with the 
respective LC50 or IC50 values in the range of reported quinolone concentrations 
occurring in the environment, and thus a possible negative impact on the natural 
population of these organisms. 
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Abstrakt 
 
Chinolonová antibiotika představují chemicky značně homogenní skupinu 
výhradně syntetických látek objevených v šedesátých letech minulého století. 
Dodnes si tato antibiotika zachovala významnou pozici v antimikrobiální terapii. 
Chinolony (nebo přesněji fluorochinolony) jsou často používané 
v humánní terapii k léčbě jak běžných, tak i závažných onemocnění a navíc jsou 
považovány za důležitou součást boje proti bioterorismu (jako bioteroristická 
zbraň je hodnocený například antrax). Někteří zástupci fluorochinolonů rovněž 
patří mezi nejčastěji používaná veterinární antibiotika, a to včetně jejich 
velkoplošného použití v chovu ryb. Jenom v samotné České republice se roční 
spotřeba fluorochinolonových antibiotik pohybuje v řádech milionů DDD 
(definovaných denních dávek).  
Fluorochinolony jako výlučně syntetické sloučeniny nemají v životním 
prostředí přirozený zdroj, proto je jejich výskyt v suchozemských i vodních 
ekosystémech považován za důsledek lidské činnosti. Nebudeme-li uvažovat o 
přímé aplikaci fluorochinolonů do vodního prostředí (jako prevenci nebo léčbu 
nemocí zvířat ve vodním hospodářství), představují vstupní bránu těchto látek do 
okolního prostředí odpadní vody. Četné vědecké práce z různých států poukázaly 
na fakt, že dokonce i po několikastupňovém čištění odpadních vod je úroveň 
fluorochinolonů  na  výtoku  z čističky odpadních vod většinou v řádu desítek až 
stovek ng L-1). Vliv fluorochinolonů na životní prostředí přitom nebyl dostatečně 
prozkoumán. 
V této práci jsem se zaměřila na vypracování ekotoxikologického profilu 
třech v České republice nejčastěji používaných fluorochinolonových antibiotik 
(ciprofloxacinu, norfloxacinu a ofloxacinu). V toxikologických testech byly 
použité čtyři sladkovodní druhy, abych získala relevantní informace o akutní 
toxicitě testovaných antibiotik. Experimentálními organismy byly řasa 
Pseudokirchneriella subcapitata, prvok Tetrahymena pyriformis, vířník 
Brachionus calyciflorus a korýš Thamnocephalus platyurus. Všechny testy byly 
provedené jako testy na akutní toxicitu. Počáteční koncentrace fluorochinolonů 
byly 12 mg L-1, 3 mg L-1, resp. 0,3 mg L-1 a pro každý test bylo připraveno 
alespoň osm různých koncentrací použitých antibiotik.  
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Získané výsledky naznačují, že akutní toxicita jednotlivých chinolonů se 
liší v závislosti na testovaném organismu. Nízká akutní toxicita byla nalezena pro 
řasu P. subcapitata a korýše T. platyurus. Na druhé straně, značnou akutní 
toxicitu vykazovala použitá antibiotika vůči vířníku B. calyciflorus (s výjimkou 
norfloxacinu) a prvoku T. pyriformis. V těchto případech byly hodnoty LC50, resp. 
IC50 srovnatelné s koncentracemi fluorochinolonů nalezenými v životním 
prostředí, což by mohlo negativně ovlivnit populace těchto organismů v jejich 
přirozeném prostředí. 
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1. Preface 
 
 Since the appearance of the first antimicrobial agents used in human and 
veterinary therapy (sulfonamides and penicillin), their importance increased 
gradually. In time, numerous chemical compounds, both naturally occurring and 
synthetic, were added to the nowadays large group of antibacterial 
chemotherapeutic agents. Antibiotics significantly decreased mortality on various 
diseases, shortened the period of healing, prevented from delayed effects of the 
disease-causing organisms. On the veterinary field antimicrobials allowed a 
considerably higher production with a decreased loss of the animals. 
 Due to the frequently use (and often overuse) of antibiotics in both human 
and veterinary therapy, several new problems have arisen in the past decades. 
Resistance of bacterial species to antibiotics definitively became an important 
issue in the antimicrobial chemotherapy. The well-known multi-resistant bacterial 
strains were one of the most severe and often lethal consequences of non-rational 
antibiotics usage. Because the resistance of microbes to antibiotics has direct 
impacts on human health, the research on this field was very intense and solved 
several vital questions. The results of this research have also been implemented in 
the praxis – the surveillance of antimicrobial agents consumption and the 
elaboration of rational antibiotic therapy guidelines may serve as good examples. 
 A completely different problem is the occurrence and fate of antimicrobial 
agents in the environment. Antibiotics in large quantities are directly applied to 
the aquatic environment in the aquaculture, and great amounts of various 
antibiotics are daily delivered via the wastewaters of both communal and hospital 
origin. The wastewater treatment plants do, in fact, eliminate a significant 
proportion of the whole amount of antimicrobials, but numerous 
chemotherapeutic agents can to various extent still be found in the final effluents 
of the wastewater treatment plants.  
The fate of most antimicrobials in the environment is unknown. Do they 
remain in the aquatic ecosystem or are they adsorbed on the soil particles and 
enter the terrestrial ecosystem? Do they undergo any kind of degradation and lose 
their antimicrobial effect? Are they stored in a particular compartment or are they 
distributed evenly to the whole environment? And most importantly: how do they 
influence the living part of the ecosystems? What are their effects on non-target 
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organisms? And what the consequences of the potentially altered ecosystems will 
be? These questions need to be answered in order to perform a proper 
environmental risk assessment of the large group of antibacterial agents. 
 
This study is focused on the ecotoxicological screening of three very 
frequently used fluorochinolone antibiotics on selected freshwater species and is 
intended to investigate the acute toxicity of tested fluoroquinolones. The tested 
compounds were chosen because they are commonly used in antibacterial therapy 
in the Czech Republic, are often found in the wastewaters in many countries and 
the knowledge about their fate in the environment and their impact on aquatic 
ecosystem is fairly poor. Published works dealing with the influence of 
fluoroquinolones on model plant and animal species are scarce and often focused 
on only one or two different species. 
Present research is related to other studies supervised by Mgr. Jitka 
Vytlačilová, which were elaborated at the Department of Pharmaceutical Botany 
and Ecology, Faculty of Pharmacy in Hradec Králové, Charles Univeristy in 
Prague. Other works deal with selected pharmaceuticals (not restricted to 
antimicrobial agents) commonly used in the Czech Republic (e.g. paracetamol). 
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Aims of the Present Research 
 
1. To determinate the acute toxicity of three fluoroquinolone antibiotics 
commonly used in the therapeutic praxis on selected freshwater experimental 
organisms. 
 Solved questions: 
• What concentration range of the antibiotics should be used for the 
ecotoxicity tests?  
• Do the selected fluoroquinolones have similar acute toxicity on the 
tested experimental organisms? 
 
2. To estimate the environmental risk of three fluoroquinolone antibiotics 
with regard to their acute toxicity on selected freshwater experimental 
organisms. 
 Solved questions: 
• Are the obtained acute toxicity data of the investigated 
chemotherapeutical agents in accordance with available published 
works? 
• Based on the obtained results, are there any environmental risks 
associated with the quinolone antibiotics tested? 
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2. Introduction 
 
At the beginning, I would like to explain the structure of the introduction 
presented. In this thesis, I deal with ecotoxicological screening of three selected 
antibiotic substances commonly used in infection treatment. For a more deep 
understanding of their effects on organisms tested, it is useful to have at least a 
fairly knowledge of the structure, chemical and biological properties of these 
antibiotic agents. Therefore, I will provide some basic information on the history 
and the therapeutic aspects of one particular group of antibiotics – namely 
quinolones – which compounds used in this research they belong to.  
Further, I will try to encompass the most important facts regarding the 
effects of antibiotic agents on wastewaters and surface waters, and their 
consequences for aquatic environment with heavy emphasis on quinolones. And 
lastly, I will deal with organisms and biological tests used for the purpose of 
ecotoxicological screening.  
 
2.1. Quinolones 
 
In the present days, there are many substances with antibiotic activity. 
Some of them are used widely, some are restricted to treatment of particular 
diseases or biological groups and some are long forgotten or not explored yet. Due 
to the excessive amount of these compounds, the classification of antibiotics was 
established; dividing them into groups based on chemical structure and origin. 
Quinolones represent a relatively homogenous group of antibacterial agents, with 
their history reaching into early 1960s and extending up to the present days. 
 
2.1.1. Characterization of Quinolones 
 
2.1.1.1. Chemical Structure and the Structure-Activity Relations 
 
The structure of quinolone antibiotics was derived originally from quinine. 
The first compound of this chemotherapeutical group to be discovered was 
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nalidixic acid in 1962. During the following years, some structural changes 
improving the pharmacokinetic and pharmacodynamic qualities were made.  
The basic chemical traits common to quinolones involve the presence of a 
heterocyclic structure (namely quinoline, less often cinnoline or naphtyridine), a 
carboxylic acid in position 3 and a ketone in position 4 (see Figure 2.1.). Positions 
3 and 4 are crucial for the antibiotic activity (Anderson and MacGowan, 2003; 
Hartl, 2006).  
 
 
 
 
 
 
 
 
 
 
 
Modifications in some positions revealed to be undesirable, while other 
changes enhanced pharmacokinetic and pharmacodynamic features of the new 
compounds. Among the most important structural manipulations was the addition 
of fluorine atom to position 6, by which a significant increase in gyrase-blocking 
activity was achieved. Compounds with this particular structural trait were named 
fluroquinolones (Domagala, 1994; Anderson and MacGowan, 2003 and 
references therein).  
For the control of potency, several positions are of great importance. Aside 
from the essential gyrase-binding site (carbons 3 and 4), groups R1, R5 and R7 
contribute to the resulting antibacterial activity (Andersson and MacGowan, 2003 
and references therein). 
All of three of quinolones used in this thesis are structurally similar, the 
main difference being a morpholine ring in ofloxacin and a cyclopropyl group in 
ciprofloxacin – both substitutions do not occur in the two other compounds (see 
Figure 2.1. The general chemical structure of quinolone antibiotics with basic structure-
activity assessment. From Anderson and MacGowan, 2003. 
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Figure 2.2.). They all contain a structural trait that allows increased biological 
availability of these compounds – namely the presence of piperazine molecule as 
the R7 substitute (Hartl, 2006).  
 
 
 
 
 
 
 
 
 
 
The cyclopropyl substitute addition in ciprofloxacin resulted in further 
increased biological availability of the antibiotic agent. Due to the presence of 
abovementioned morpholine ring in ofloxacin, this substance is chiral and can be 
used as racemic mixture or enantiomer (named levofloxacin; Hartl, 2006). 
 
2.1.1.2. Important Properties of Quinolones in Relation to Environmental 
Risk Assessment 
 
 According to available literal sources, photochemical properties of 
quinolones have been studied extensively because of the impact of the relatively 
low photostability of these antibacterial drugs on humans and animals (see 
Chapter 2.1.2.2.). On the other hand, as will be discussed in Chapter 2.2.2.2., 
photodegradation seems to be a very efficient process of the elimination of some 
quinolone antibiotics from the environment.  
During the process of the photodegradation of quinolones in neutral 
aqueous solutions, several reactive species are generated – e.g. carbon centered 
Figure 2.2. The chemical structure of 
fluoroquinolones used in this research. 
Upper left – ciprofloxacin, upper right – 
norfloxacin, bottom – ofloxacin. Modified 
from Lipsky and Baker, 1999. 
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radical, hydroxyl radical and singlet oxygen were reported (Viola et al., 2004 and 
references therein; Vargas et al., 2009).  
Fasani et al. (2004) studied the photochemistry of lomefloxacin. The 
authors reported that lomefloxacin and most likely other 8-halo-substituted 
fluroroquinolones endure fragmentation of C-F bond under various experimental 
conditions that results in the generation of a cationic structure, which is both 
chemotherapeutic inactive and aggressive (Fasani et al., 2004) 
 Other structural part of quinolones most prone to degradation after light 
exposure is the piperazine ring in position 7 (occurring e.g. in ciprofloxacin, 
norfloxacin and ofloxacin; Córdoba-Díaz et al., 1998 and references therein). 
 
 Quinolones, as shown in previous chapter, contain both acidic and basic 
groups, thus marking them as zwitterions. The dissociation constants (pKa) for 
these compounds are environmentally relevant – e.g. norfloxacin and 
ciprofloxacin occur as zwitterions in very similar pH values (Lindberg et al., 
2006).  
The pH value of environment has, to an extent, an influence on the 
distribution of quinolones (e.g. Belden et al., 2006 in their study of ciprofloxacin 
sorption onto particulate organic matter under different pH values). 
Nowara et al. (1997) reported that quinolones (e.g. enrofloxacin) appeared 
to be in the clay soil solutions (pH around 6.0) as anions and tended to interact 
with the exchangeable cations bound to soil surface.  
However, pH value of raw sewage is higher (7.1 – 7.5; Lindberg et al., 
2006) and quinolones should exist as zwitterions in this pH range – which means 
that the sorption of quinolones to particulate matter may be influenced by other 
factors. Golet et al. (2003) and Lindberg et al. (2006) suggested hydrophobic and 
electrostatic interactions as factors impacting sorption of quinolones to particulate 
matter at higher pH values. 
 
2.1.2. Therapeutic Use of Quinolones 
 
 Since the discovery of quinolones, these antibacterial agents have their 
place in treatment of various infection diseases. Not all of these substances are 
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used in the present human medicine – some of them being abandoned in favor of 
more effective agents and some restricted in the clinical use because of their 
adverse effects. For practical purposes, quinolones are divided into several 
generations in accordance to their structure and antibiotic activity. 
 
2.1.2.1. Generations of Quinolones 
 
Ball (2000) suggested that there are at least two different approaches of 
classification of quinolones: the first one being the chronological, based on 
development of new molecules, and the second one implying “natural selection”, 
including for example the frequency of prescription of various quinolones. 
However, there are several more opinions of the classification of this 
chemotherapeutic group, distinguishing or not between quinolones, 
naphtyridones, fluoroquinolones and other sub-groups based on their minor 
chemical changes and placing particular antibacterial agents into 3 or 4 
generations respectively, sometimes with the addition of several sub-generations. 
First-generation quinolones are represented by the early substances 
discovered back in the 1960s – nalidixic acid (sometimes considered as a member 
of the naphtyridones), oxolinic acid and the very first of the fluoroquinolones – 
flumequin. These quinolones were used for treatment of the urinary tract 
infections, because of their pharmacokinetic properties (Ball, 2000). Flumequin is 
still used for veterinary purposes (e.g. in treatment of bacterial infection in fish – 
Lalumera et al., 2004). 
All of the three quinolones tested in this work (norfloxacin, ciprofloxacin 
and ofloxacin) belong into the 2. generation, which is characterized by relatively 
wide antibacterial activity and convenient pharmacokinetic properties when 
compared to 1. generation. All of them have enhanced activity, particularly 
against Gram-negative pathogens, but with restricted effect on Gram-positive 
bacteria. Among this group of antibacterial agents, ciprofloxacin is the most 
potent against Pseudomonas aeruginosa (Ball, 2000; Hartl, 2006). 
 Chemotherapeutic agents of the second generation have been available 
since the mid-1980s and have brought important changes in treatment of several 
infections. Second-generation quinolones are still widely used in practice. The 
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most common indications of these chemotherapeutic agents are: urinary tract 
infections, skin and soft tissues infections, acute exacerbations of chronic 
bronchitis, nosocomial pneumonia, chlamydial infections, gonorrhea, and 
infections caused by P. aeruginosa (Hooper, 1998; Ball, 2000; Lincová and 
Farghali, 2007). Furthermore, ciprofloxacin seems to be a very reliable agent 
against Bacillus anthracis (considered as a bioterrorist weapon) infection and in 
post-prophylactic treatment when administered twice daily (Deziel et al., 2005). 
On the other hand, there are some evidences that use of ciprofloxacin against 
Gram-positive bacteria (namely Streptococcus pneumoniae) is not appropriate and 
ciprofloxacin should be replaced by a more active chemotherapeutic agent, e.g. 
levofloxacin (Lister and Sanders, 1999). 
Third-generation quinolones (sparfloxacin, grepafloxacin, tosufloxacin) 
are represented by substances with renewed strong antibacterial activity against 
Gram-positive bacteria (such as the genus Streptococcus), but with decreased 
activity against P. aeruginosa. This balanced broad spectrum of activity is used in 
pulmonary bacterial infection treatment. Furthermore, these agents have a very 
favorable pharmacokinetic profile, which allows a once-daily administration 
scheme (Ball, 2000).  
As to fourth-generation quinolones (moxifloxacin, gatifloxacin, 
trovafloxacin), these substances are considered to be reserved antibiotics meant 
only for treatment of life-endangering infections, which cannot be eradicated by 
other chemotherapeutical agents. They have enhanced activity against Gram-
positive bacteria and their pharmacokinetic profile allows their administration in 
only one daily dose (Hartl, 2006; Lincová and Farghali, 2007). 
 
2.1.2.2. Restriction in Therapeutic Use of Quinolones 
 
 Quinolones, as every other group of pharmaceuticals, are not without 
adverse effects. Because of them, quinolones are not suitable in treatment of all 
human patients. 
 Generally, quinolones are well-tolerated antibiotics, with adverse effects in 
about 2 – 8% of patients. The most common adverse effects of quinolones are 
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(i) gastro-intestinal effects such as diarrhea, (ii) phototoxicity and (iii) arthropathy 
(Lincová and Farghali, 2007). 
 Phototoxicity of quinolones is more pronounced in compounds with 8-
halo-substitution (e.g. Hartl, 2006). Tokura (1998) suggested that quinolones have 
the same photoantigenic epitope (recognizable by both T cells and 
imunoglobulins) resulting in fluoroquinolone photosensitivity and cross-
reactivity. 
 Regarding arthropathy, patients should be warned beforehand to avoid 
physical activity during therapeutic treatment with quinolone antibiotics. Because 
of uncertainty of atrhropathic influence in children, quinolones are generally 
contraindicated in children patients, except for several indications (Lincová and 
Farghali, 2007). The newest data on quinolone-induced arthropathy, as well as 
clinical application of quinolone antibiotics in children patients, are explored by 
Sendzik et al. (2009). 
 
2.1.2.3. Current Data on the Therapeutic Use of Quinolones in the Czech 
Republic 
 
As of January 2010, not all quinolones are in therapeutic use in the Czech 
Republic. Following information is based on data displayed at the website of the 
State Institute for Drug Control – for additional information, more details and 
product names see www.sukl.cz. 
According to the State Institute for Drug Control, in the Czech Republic 
there are no medicinal products with the first-generation quinolones as the 
pharmacologically active compound.  
Second-generation quinolones represent the most frequently used group of 
quinolones in the Czech Republic. Of the quinolones presented in this study, 
norfloxacin is the most commonly prescribed. According to the State Institute for 
Drug Control, there are nearly 500 registered medicinal products in the ATC 
group J01MA (Fluoroquinolones). Of all these products, over 350 have 
ciprofloxacin as the pharmacologically active compound, 12 of them have 
ofloxacin and only 7 norfloxacin. Several of the medicinal products are in the 
form of an infusion solution, and therefore intended for hospital use only (for 
further details, product names and forms see www.sukl.cz). 
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There are currently no registered medicinal preparations with third- or 
fourth-generation quinolones in the Czech Republic. 
 
Currently, available data on quinolones consumption regardless of 
administration route (i.e. all types of medicinal preparations) and patient 
(ambulant or hospitalized) in the Czech Republic are from the years 2007 and 
2008 (based on the data provided by AISLP (Prague); see Table 2.1.). Norfloxacin 
represents the fluoroquinolone with the highest consumption in both years, while 
ofloxacin is the antibacterial agent with the lowest consumption in both years. As 
to financial value of the fluoroquinolone antibiotics use in the Czech Republic,   
in 2007 the costs for quinolones was around 166 millions CZK, in 2008 the costs 
for quinolones were higher, around 174 millions CZK (data obtained by AISLP, 
Prague). 
 
 
 
  Thousands of DDD % of All Quinolones DDD 
Quinolone 2007 2008 2007 2008 
Ciprofloxacin 1 729 1 888 30,99 33,80 
Norfloxacin 2 375 2 306 42,56 41,28 
Ofloxacin 1 334 1 263 23,91 22,61 
All Quinolones 5 580 5 586 100,00 100,00 
 
 Overall, according to ESAC (European Surveillance of Antimicrobial 
Consumption), the antibiotic consumption in ambulant patients (i.e. excluding 
hospitals) in Czech Republic in 2006 lies in the range from 14.4 to 18.69, 
expressed in defined daily doses (DDD) per 1000 inhabitants per day, which is the 
second-lowest level of use of antibiotics in the countries with antibiotic 
surveillance by ESAC (for further details see the internet pages of European 
Surveillance of Antimicrobial Consumption, http://app.esac.ua.ac.be/public/). 
 
2.2. Environmental Exposure and Risk Assessment of 
Antibacterial Agents in Surface and Waste Waters 
 
 Chemotherapeutic agents were proved to be a powerful and irreplaceable 
means against various bacterial infections. However, the consumption of these 
Table 2.1. Quinolones consumption in the Czech Republic in years 2007 and 2008. 
Data obtained from AISLP, Prague. DDD = defined daily dose 
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substances is, especially in the last decades, excessive. For example, Wise (2002) 
estimated the annual use of antibiotics to be about 100 000 to 200 000 tons 
globally. The use of antibiotics is not restricted to the area of human medicine; it 
includes veterinary, agri- and aquacultural purposes. During the last years, the 
concern about the effects of antibiotics use on environment significantly increased 
and several studies on this topic were conducted worldwide (e.g. studies of the 
last decade focused on quinolones: Halling-Sørensen et al., 2000; Golet et al., 
2002; Cardoza et al., 2005; Lindberg et al., 2006; Xu et al., 2007).  
The most imminent problem is the possible development of resistance to 
chemotherapeutic agents in bacteria that could result in impairment of infections 
treatment in human and animal patients. Secondly, there is the risk of affecting the 
natural inhabitants of aquatic and terrestrial environment and its following 
consequences could result in degradation of community structure and impaired 
function of the whole ecological system. And thirdly, there are also practical 
issues of exposing humans and/or animals to inadequate amounts of antibiotics 
due to the use of sewage treatment plant’s solid products (e.g. their use in 
fertilizers). 
 
2.2.1. Approaches on the Risk Assessment of Use of Antibiotics 
on the Environment 
 
There are several ways to look at the risk assessment of antibiotics use on 
environment. As to administration point of view, different countries utilize 
different official procedures in order to evaluate the risk of use of chemically 
active entities – e.g. Bound and Voulvoulis (2004) provide a comparison of risk 
assessment strategies of pharmaceuticals in the aquatic environment. 
From a “practical” point of view, there are several aspects of the flow of 
the antibiotic in the environment that can be evaluated. Antibiotics administered 
to ambulant or hospitalized patients undergo to some extent chemical changes in 
the human body – their metabolism is dependent on several factors including 
chemical structure and enzymatic apparatus of the organism – and are eliminated 
in the form of more or less active compounds into the sewage waters. From this 
point of view, the sewage treatment plants represent a good starting platform.  
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Based on their goals relevant to environmental risk assessment discussed 
in this thesis, in following chapters there are listed the basic three types of 
scientific projects which can be found in literal sources (i.e. analytical studies, 
mass flow studies, and ecotoxicological studies). In order to avoid abundance of 
information provided, all works mentioned in the following text are at least 
partially focused on quinolones. 
 
2.2.1.1. Analytical Studies 
 
A number of studies focused solely on determination of various 
pharmaceuticals in sewage waters or sludge, and on improving or simplifying of 
the analytical methods (frequently used were liquid chromatography methods)  
designed for these purposes (e.g. Golet et al., 2001; Ferdig et al., 2005; Bueno et 
al., 2007; Xu et al., 2007). A comprehensive review on analytical methods for the 
determination of antimicrobial agents (including fluoroquinolones) in various 
types of surface waters is provided by Seifrtová et al. (2009). 
The main contributions of these studies are: (i) determination of 
chemotherapeutic agents concentrations in different environmental samples (raw 
sewage, sludge, sewage treatment plant effluents, surface waters and soil samples) 
and (ii) gaining of efficient analytical methods that can be applied in common life 
use in various institutions. And while both aims are very reasonable and bring an 
insight on the topic, no actual risk assessment is provided by these studies.  
 
2.2.1.2. Mass Flow Studies 
 
Mass flow studies are works that try to pursuit the flow of pharmaceuticals 
in the environment. These studies include exploring the fate of antibiotics during 
the whole process of sewage water treatment or the distribution of the 
chemotherapeutical agents to aquatic or terrestrial environments. The works were 
carried out mostly as short-term case studies as shown on following examples of 
studies dealing with quinolone antibiotics. 
Lindberg et al. (2006) conducted their study in a sewage treatment plant in 
Sweden, receiving water from an area inhabited with a population of 
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approximately 80 000 people. They used liquid and solid samples collected on 
three days on various stages of sewage treatment in order to determinate the 
degradation of different antibiotics, including ciprofloxacin and norfloxacin, and 
to estimate the efficiency of the mechanical, chemical and biological treatment of 
waste waters.  
Slightly different circumstances were investigated by Golet et al. (2002) in 
their field work in Switzerland. The scientists tried to determinate the exposure of 
fluoroquinolones (10 substances) in waste and river water of the Glatt Valley 
Rivershed, located in a heavy populated area near Zurich (175 000 inhabitants, 
260 km2). The experiment was performed using samples obtained in two different 
seasons (one-week composite samples collected in winter and in summer). 
An analogical study was conducted by Nakata et al. (2005) who 
researched the occurrence of a wide range of fluoroquinolones (9 substances) in 
effluents of a sewage water treatment plant and adjacent surface waters on the 
USA/Canada border. Only ciprofloxacin was found in final effluent of the sewage 
water treatment plant and probably due to dilution of the effluent, none of the 
tested antibiotics was detected in sampled natural waters. 
Cardoza et al. (2005) researched the factors affecting disappearance rate of 
ciprofloxacin in surface waters, using both field and laboratory systems. The 
study focused on two main factors that influence the elimination of ciprofloxacin 
from aquatic environment – photodegradation and adsorption onto particulate 
organic carbon. 
Mass flow studies often use the knowledge gained in analytical studies. 
Their significance is in verifying the concentrations of antibiotics in various 
environments as well as – at least to some degree – in trying to assess the risks of 
antibiotics use. However, in most cases, the risk assessment is reduced to 
comparing obtained data with literal sources and no ecotoxicological tests were 
actually performed. 
 
2.2.1.3. Ecotoxicological Studies 
 
 As to the accuracy of environmental risk assessment, these are the studies 
that bring the most valuable data. The goal of these works is to elaborate the 
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reliable ecotoxicological profile of respective pharmaceuticals using battery of 
toxicity tests. In order to properly assess the toxicity of a substance, organisms of 
all three trophic levels (i.e. producer, consumer and decomposer) need to be tested 
– it is widely accepted that any effect on any of the trophic levels may have heavy 
impact on the other trophic levels and disturb the whole ecosystem.  
Aside from tests providing data concerning acute toxicity, there is also the 
need for performing tests enlightening both sub-chronic and chronic toxicity of 
chemical substances. Because of these facts, ecotoxicological studies are largely 
time-consuming and financially demanding. 
However, not every single ecotoxicological study does, in fact, cover all of 
the mentioned trophic levels. For example, Nie et al. (2009) focused on the effect 
of two chemically highly unrelated compounds (one of them being norfloxacin) 
on a freshwater algal species Scenedesmus obliquus – an autotrophic organism 
representing the producers. The reduction of tested organisms to one single 
species allowed a more in-depth research of the impacts of ciprofloxacin on the 
metabolism and growth of this specific microalga; not only the estimation of 
EC50.  
Similarly, Charoy (1995) aimed in the research for exploring the changes 
in swimming pattern of Brachionus calyciflorus (a freshwater rotifer) under toxic 
stress induced by four different toxicants rather than just determining basic 
toxicological parameters. 
A study focused on effects of 25 pharmaceuticals most commonly 
occurring in aquatic environment on an aquatic higher plant species Lemna gibba 
was carried out by Brain et al. (2004). Among the five quinolone antibiotics tested 
(ciprofloxacin, norfloxacin, ofloxacin, levofloxacin and lomefloxacin), 
lomefloxacin showed the highest phytotoxicity. Overall, their toxicity 
demonstrated as bleaching of new fronds (due to damage of chloroplasts) and 
growth inhibition resulting in development of small new fronds and distinct 
anatomical changes. 
Ecotoxicological aspects of two quinolones and their photodegradation 
intermediates were marginally studied by Sirtori et al. (2009a) in the form of 
measurement of the inhibition of bioluminescence emitted by the bacterium 
Vibrio fischeri. 
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A wide range of biological tests was performed by Halling-Sørensen et al. 
(2000) for ciprofloxacin and two other antibiotics. In this work, activated sludge 
bacteria, a green alga, a cyanobacterium, zooplankton and a fish species were 
used. 
 
2.2.2. Quinolones in the Environment 
 
 According to available literal sources, quinolones are often found 
in the environment. And while sources of these chemotherapeutical agents are 
mostly known, it is the fate of the compounds that is not explored enough. 
 
2.2.2.1. Occurrence of Quinolones in the Environment 
 
Kümmerer (2009), in the first part of his two-part comprehensive review 
on antibiotics in aquatic environment, discussed also the natural occurrence of 
antibacterial agents in soils and surface waters. While some groups of 
chemotherapeutics can be found in trace concentrations naturally (e.g. β-lactams 
or streptomycins produced by soil bacteria), quinolones are, however, purely 
synthetic products and their presence in ecosystems is the result of human 
activity. 
In concordance of the frequency of their therapeutic use, mostly second-
generation quinolones are present in the environment. In the following text, an 
overview of both occurrence and reported concentrations of quinolone antibiotics 
is provided. 
In raw sewage, the concentrations of quinolones were shown to occur in 
concentrations of the order of hundreds ng L-1 (from 200 to 300 ng L-1 in 
Lindberg et al., 2006; from 270 to 600 ng L-1 in Golet et al., 2003; from 300 to 
600 ng L-1 in Golet et al., 2002 and from 350 to 600 ng L-1 in Peng et al., 2006), 
while in final effluent the concentrations of these antibiotics were significantly 
lower – reduced down to one fifth or less of the original content (i.e. 40 to 
70 ng L-1 in Lindberg et al., 2006), or to undetectable concentration (ofloxacin 
content in Peng et al., 2006). 
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For several Canadian sewage treatment plants, Miao et al. (2004) analyzed 
only final effluent samples, however, their findings on three quinolones 
concentration (ciprofloxacin, norfloxacin and ofloxacin) are very similar – from 
50 to 120 ng L-1 with the highest content observed for ciprofloxacin.  
Ciprofloxacin concentration was studied also by Hartmann et al. (1999) in 
composite waste water samples collected from different waste water streams of 
German hospitals and it ranged from 0.7 to 125 ng L-1. 
Zorita et al. (2009) focused on determination of various pharmaceuticals 
(including ciprofloxacin, ofloxacin and norfloxacin) in different sewage waters in 
Sweden. Their results show that quinolone antibiotics can be detected also in 
household sewage in concentrations varying from 16 ng L-1 (ofloxacin) to nearly 
4000 ng L-1 (ciprofloxacin). Concentrations of quinolone antibiotics in hospital 
sewage were as expected higher than those in household sewage. 
Information on concentration of quinolones in solid samples, except for 
sludge samples of sewage treatment plants, is quite scarce (noted also by 
Hernando et al., 2006). Concentration of quinolones in the sludge samples are 
generally in order of low mg kg-1 dry substance (e.g. Lindberg et al., 2007) and 
because of these high contents, the sludge should be treated accordingly.  
As for other solid samples tested on quinolone antibiotics content, 
Lalumera et al. (2004) determined content of flumequin in sediment samples of 
several Italian fish farms to be fairly low, mostly around the detection limits 
(0.1 µg kg-1 DW) with an extreme exception of nearly 600 µg kg-1 DW. 
 
2.2.2.2. Factors Influencing the Elimination of Quinolones from 
Environment 
 
Lindberg et al. (2006) suggest that quinolones undergo to a great extent 
the process of sorption onto sludge, as the reduction from aqueous phase was 
approximately 80% for both ciprofloxacin and norfloxacin. On the other hand, 
Halling-Sørensen et al. (2000) found no significant amount of ciprofloxacin to be 
sorbed onto sludge. The distribution between water and particulate matter may 
depend on water temperature as suggested by Lindberg et al. (2006) who 
compared relative sorption of quinolones onto sludge and temperature of water 
samples with data from a work of Golet et al. (2003). Cardoza et al. (2005) 
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observed that the sorption of ciprofloxacin onto particulate matter is higher in 
acidic environment and a similar observation was noted by Nowara et al. (1997). 
Sorption on particulate matter seems to be one of the factors influencing 
the fate of quinolones in environment. Cardoza et al. (2005) conducted both field 
and laboratory experiments on ciprofloxacin and concluded that the proportion of 
particulate organic carbon affects the amount of ciprofloxacin in the environment: 
the not-sorbed fraction of the drug can undergo photodegradation (discussed in 
Chapter 2.1.1.2.), while the fate of ciprofloxacin sorbed onto solid particles 
remains fairly undisclosed. That sorption onto particulate material affects the 
proportion of ciprofloxacin, which can be involved in photodegradation, was 
confirmed by Belden et al. (2006): the photodegradation rate of ciprofloxacin was 
2.3-fold slower in the presence of particulate organic material when compared to 
aqueous solution with no particulate matter. 
During the mechanical and chemical treatment of quinolones in the sewage 
treatment plant, the efficiency of removal of quinolones (namely ciprofloxacin 
and norfloxacin) was around 55% and during the biological treatment only about 
35% (Lindberg et al., 2006). Also Halling-Sørensen et al. (2000) revealed that 
ciprofloxacin and structurally similar substances are to a great degree resistant 
against biodegradation in sludge. 
As biodegradation appears not to be the most effective route of quinolones 
elimination, photodegradation became the central spot of scientific interest. 
Sirtori et al. (2009a) focused on the disappearance of flumequin and nalidixic acid 
of water solutions after two different solar photochemical treatments (the active 
compounds being TiO2 and Fe2+ in combination with H2O2, respectively). The 
Photo-Fenton treatment (Fe2+/H2O2) was confirmed as being the more effective – 
within 20 minutes of illumination, both pharmaceuticals with initial concentration 
20 mg L-1 were totally eliminated. When using heterogeneous photocatalyst with 
TiO2, the degradation of nalidixic acid was slower and not sufficient enough. 
The process of photodegradation has a positive effect on the 
mineralization of quinolones. Under solar photochemical treatment, the 
proportion of mineralized pharmaceuticals was about 80%, while quinolones 
undergoing the standard sewage water treatment were mineralized to a much 
lesser extent (Sirtori et al., 2009a). 
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Based on these findings, Sirtori et al. (2009b) suggested the treatment with 
Photo-Fenton as the final step in treatment of sewage waters. The addition of 
this procedure provides great time savings as well as very efficient degradation of 
pharmaceuticals even highly recalcitrant to biodegradation solely (such as 
nalidixic acid). Berto et al. (2009) also tested the Photo-Fenton as a possible step 
in sewage water treatment and their results confirm the effectiveness of this 
degradation process – within 30 minutes, mean chemical oxygen demand (COD) 
was reduced by over 40% and biological oxygen demand (BOD) by 50%. 
Further, Sirtori et al. (2009a) revealed a significantly lower toxicity of 
photodegradation intermediates of two fluoroquinolones to the bacterial species 
Vibrio fischeri. This observation implies that photodegradation not only 
eliminates quinolones from environment, but also decreases the toxicity of these 
chemotherapeutical agents early in the process. 
 
2.3. Tests and Experimental Organisms Used in the 
Ecotoxicological Screening of Chemical Substances 
 
2.3.1. Ecotoxicological Tests 
 
As mentioned in Chapter 2.2.1.3., biological tests used in environmental 
risk assessment are designed to be either short-term, investigating acute toxicity of 
tested substance, or long-term, aiming for estimation of chronic (or sub-chronic, 
respectively) toxicity.  
In general, the bioassays for ecotoxicological screening should be simple, 
preferably low-cost and accurate. The methods of endpoint measurement often 
involve spectral methods, e.g. colorimetry or measurement of optical density. The 
screening tests are optimized for each experimental organism. 
 When dealing with the ecotoxicological studies focused on antibiotics, 
some authors suggest (e.g. Kümmerer, 2009) that using short-term tests is not 
sufficient – as most mechanisms of resistance development in bacteria are 
functional in time span of several generations (i.e. order of days and not hours). 
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2.3.2. Experimental Organisms in Ecotoxicological Screening 
 
The demands on experimental organisms are quite high: they (i) have to be 
representative for a larger group of species, (ii) should have well-known 
background data (biological properties, behavioral studies, ecology, metabolism 
and enzymatic apparatus), (iii) their growing should be easy to maintain and 
reproducible. Furthermore, the selected organisms should correspond with the 
environmental conditions of the particular research – e.g. using freshwater, sea 
and estuarial species in concordance with tested samples. 
Not all plant and animal species meet these demands. However, the range 
of species used for experimental means is still fairly wide as new information is 
daily gained. In the following chapters, the most common species used for 
ecotoxicological screening purposes are listed. In addition, some basic 
characterization of the species and the most commonly evaluated biomarkers are 
provided. 
 
2.3.2.1. Prokaryotic Organisms 
 
 Prokaryotic organisms represent a heterogeneous biological group with 
substantially different cell structure than those of plant or animal species. In 
ecotoxicological studies, they are valued for simple maintenance, rapid growth 
and short life-cycle turn. 
 The bacterial species probably most exposed to different toxicants are 
those of activated sludge in sewage treatment plants.  
Of other bacterial species, Gram-negative bacteria Vibrio fischeri and the 
Gram-positive bacteria Bacillus subtilis are also often used as the indicators in 
ecotoxicological tests.  
 Botsford (2002) performed an extensive ecotoxicological testing with the 
bacterium Sinorhizobium meliloti. The research compared 23 other tests with the 
method using Sinorhizobium and concluded that bioassay with this bacterium 
represents a quick, simple and inexpensive method (Botsford, 2002). 
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2.3.2.2. Plant Species 
 
 Plants are considered as the first trophic level – the primary producers, 
although there are several exceptions – parasitic plants being the most blatant one. 
Plant material can be usually obtained at low cost and it is easy to work with. The 
knowledge gained from experimental work with plant species is quite extensive, 
but its extrapolation toward animals and, more specifically, humans is due to 
crucial differences between plants and animals very restricted. Lowe et al. (1995) 
suggested that the potency of using plant material instead of animal and/or human 
is high if an acceptable plant model is used. 
 In the numerous ecotoxicological studies, a large variety of plant species is 
used. Very common are tests conducted on non-vascular plants, esp. algae. 
According to available literal sources, algal genera Chlorella, Cladophora, 
Pseudokirchneriella (formerly Selenastrum) and Scenedesmus seem to be of the 
great interest, but there are also other species, frequently used for specific 
purposes. Using ecotoxicological test with Chlorella vulgaris was suggested as an 
appropriate treatment of hazardous waste waters of various origin by Silva et al. 
(2009).  Nunes et al. (2008) explored the possibilities of the use of the marine 
microalga Tetraselmis chuii in ecotoxicology, pronouncing it as a suitable 
experimental organism for marine environment. 
The use of algae in ecotoxicological testing is assessed in an in-depth 
review by Amparado and Persoone (1996).  
 As to vascular plants, ecotoxicological tests are performed on both 
terrestrial and aquatic species. The genus Lemna (and particularly species Lemna 
gibba, duckweed) is one of the most common plants used in testing of 
pharmaceuticals as well as non-pharmaceutical toxicants in aquatic environment. 
Terrestrial higher plants of the Brassicaceae family (e.g. Sinapis alba, Letuca 
sativa, Raphanus sativus) also often serve as experimental material. 
 Lowe et al. (1995) discussed the possibility of using plant tissue cultures 
in ecotoxicological screening. The main advantage of this experimental system is 
the close resemblance of protoplasts (naked plant cells that can be isolated 
enzymatically) to cultured animal cells. 
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 Generally, growth inhibition is the most inspected endpoint in 
ecotoxicological studies performed on plants. It can be expressed as mass weight, 
number of cells, germination capacity or other appropriate surrogate. Also 
photosynthesis interference of tested plant species is very often the focus of 
ecotoxicological studies (e.g. Nie et al., 2009 and Sánchez-Fortún et al., 2009 for 
the freshwater microalga Scenedesmus or Brain and Cedergreen, 2009 – see text 
bellow). 
A comprehensive review of plant biomarkers used in ecotoxicology is 
given by Brain and Cedergreen (2009). This work compiles information gained 
from over 150 experimental studies. Biomarkers are divided into 10 groups, 
including genes, enzymes, photosynthetic pigments and chlorophyll fluorescence 
measurement. 
 
2.3.2.3. Invertebrate Animal Species 
 
 For ecotoxicological screening purposes mostly invertebrate animal 
species are used, mainly because of ethical and legislative issues. Rotifers and 
small crustaceans are proved to be suitable experimental organisms with favorable 
features concerning their keeping (e.g. a short life cycle, high reproductive rate 
and ease of culture).  
 As stated by Snell and Janssen (1995), the use of rotifers in 
ecotoxicological screening increased significantly since 1990s. In their review on 
the role of rotifers in ecotoxicology, the authors discuss the advantages of rotifers 
as experimental organisms from several aspects. According to Snell and Janssen 
(1995), especially the genus Brachionus is of the great interest, although others 
have been tested (such as Philodina in early 1970s or Dicranophorus in late 
1970s).  
The crustaceans represent another group of aquatic animals used in 
ecotoxicological studies. Among them, especially the genus Artemia (especially 
the marine species Artemia salina) is in the central point of scientific interest. The 
possibilities of this particular genus in ecotoxicology were explored by Nunes et 
al. (2006).  
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As for freshwater crustaceans, the cladoceran crustacean Daphnia magna 
is probably the most frequently used experimental organism. The variety of 
ecotoxicological assays that can be performed with this species is reviewed for 
example by Martins et al. (2007). An experimental organism with results 
comparable to D. magna was reported by Versteeg et al. (1997). The authors 
investigated the possibilities of the use of the genus Ceriodaphnia dubia in 
ecotoxicological studies and found that data obtained in studies with C. dubia are 
equivalent to those obtained with D. magna (Versteeg et al., 1997). The suitability 
of D. magna utilization in ecotoxicology was, however, questioned by Koivisto 
(1995) who concluded that D. magna may be less sensitive to pollutants than 
other crustaceans because of its specific properties (such as size and habitat).  
 For terrestrial environmental pollution studies, annelids are of the great 
interest. Lowe and Butt (1997) evaluated the use of earthworms in chronic 
ecotoxicological studies and suggested the use of Eisenia andrei rather than the 
previously most used species E. fetida because of a better genetically homogenity. 
 
The most frequent endpoints in ecotoxicological tests with invertebrate 
animal species are mortality, reproduction analysis and changes in behavior. Snell 
and Janssen (1995) provide an overview of biomarkers that can be determined in 
rotifers. 
 
2.3.2.4. Experimental Organisms Used in the Present Research 
 
In this thesis, only freshwater experimental organisms were used. For the 
ecotoxicological screening purposes following species were tested: the algal 
species Pseudokirchneriella subcapitata, the ciliate protozoan Tetrahymena 
pyriformis, the rotifer Brachionus calyciflorus and the crustacean 
Thamnocephalus plytyurus. For further information, see Chapter 3.2.1. 
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3. Materials and Methods 
 
3.1. Materials 
 
3.1.1. Tested Pharmaceuticals 
 
For all toxicity tests conducted, three quinolone antibiotics were used: 
ciprofloxacin, norfloxacin and ofloxacin. All of them were of analytic grade 
quality and all three were purchased from Sigma Aldrich, Germany. Due to their 
chemical and physical properties, both solid chemicals and their solutions were 
stored at low temperature and wrapped with thin aluminum foil in order to protect 
them from any light sources. The solutions were utilized within a week of 
preparation, or new solutions were prepared.  
Potassium dichromate (analytical grade quality, purchased from Fluka, 
Germany) was used for reference toxicity tests as a compound with a good-
defined toxicity concentration for all tested organisms. 
 
3.1.2. Plant and Animal Material 
 
In order to determinate the acute toxicity of selected antibiotics on all three 
basic types of organisms based on their trophic levels (i.e. producer, consumer 
and reducer), several species were used. All selected experimental organisms are 
freshwater species frequently used in ecotoxicological screening of various 
pharmaceuticals.  
Further details regarding experimental organisms included in this thesis 
are listed in sections describing the individual toxicity tests conducted. 
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3.2. Methods 
 
3.2.1. Toxicity Tests 
 
All of the selected toxicity tests were conducted according to their 
standard operational procedures, unless stated otherwise. The TOXKITs were 
purchased from MicroBio Tests Inc., Nazareth, Belgium. In this thesis, following 
toxicity tests were performed (listed in alphabetical order): 
 
3.2.1.1. ALGALTOXKIT F™ 
 
This TOXKIT represents toxicity test with the freshwater algal species 
Pseudokirchneriella subcapitata (formerly known as Selenastrum capricornutum; 
see Fig. 3.1.) – a typical producer. The used algal culture was de-immobilized and 
then algal inoculum was prepared according to standard operational procedure. 
Prior to testing, algal density of approximately 1 million cells mL-1 in the 
inoculum was determined. Dilution series of both investigated quinolone 
antibiotics and potassium dichromate dilution were prepared and then algal 
suspension was added. For each of the tested chemical compounds 
8 concentrations of toxicant were prepared. The real concentrations started at 
12 mg L-1 for the antibiotics and at 32 mg L-1 for potassium dichromate. 
 
 
 
 
 
 
 
 
 
Algae-toxicant dilutions and control samples were cultured in specific 
10 cm long test vials. Test vials were placed into the holding tray in a random way 
Figure 3.1. The freshwater microalga Pseudokirchneriella subcapitata.      
From www.lifesciences.napier.ac.uk  
  36 
(with allowed air-exchange space) and put into an incubator at 25 °C with a 
constant and uniform illumination. Data were obtained after 0 and 72 hours of 
incubation.  
The main difference from the ALGALTOXKIT F™ standard operational 
procedure was data collecting: the required spectrophotometer equipped with a 
holder for 10 cm cells was not available; therefore manual cell-number counting 
had to be accomplished. A light microscope at 400-fold magnification and a 
Bürker cell with ruled square measuring were utilized. The samples were 
observed in bright field and cells were counted according to a prior designed cell-
counting system. 
 
3.2.1.2. Modified PROTOXKIT F™ 
 
A toxicity test designed for acute toxicity determination using a freshwater 
ciliated protozan – Tetrahymena pyriformis (see Figure 3.2.). Slightly method 
modifications were implemented compared to standard operational procedure. 
Instead of 1 cm polystyrol spectrophotometric test cells polycarbonate multiwell 
test plates (with 96 test wells) were used. For a more detailed test schema see 
Figure 3.3.  
 
 
 
 
 
 
For each of the tested chemical compounds 15 concentrations of the 
respective toxicant were prepared. The real concentrations started at 3 mg L-1 for 
the antibiotics and at 8 mg L-1 for potassium dichromate. 
The whole process of test plates’ preparation for measurement was 
conducted in a laminar flow box. Test plates were then placed into an incubator at 
25 °C without illumination. Data were obtained after 0, 24 and 48 hours of 
incubation. The test plates were measured with the use of the anthos WinRead 
Figure 3.2. The freshwater ciliated protozoan Tetrahymena 
pyriformis. From www.cadaster.eu.  
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software (Salzburg, Austria). Optical density of samples was measured at 562 nm 
directly in the test plates. 
 
 
 
 
 
 
 
 
 
 
 
 
3.2.1.3. ROTOXKIT F™ ACUTE 
 
It is an acute toxicity test with a freshwater rotifer – Brachionus 
calyciflorus (Figure 3.4.). Following standard operational procedure, one day 
prior to the start of the toxicity test rotifer cysts were hatched in order to obtain 
test organisms of proper age (i.e. 0 to 2 hours old).  
 
 
 
 
 
 
 
Figure 3.3. The multiwell test plate used in the modified acute toxicity test with T. pyriformis.  
Row B – peptone (200 µL), row C – peptone (150 µL) + tested chemical compound 
solution (50 µL), row D – peptone (150 µL) + Tetrahymena culture (50 µL), rows E – G – (three 
duplications) peptone (100 µL)+ tested chemical compound solution (50 µL) + Tetrahymena 
culture (50 µL). Columns 2 – 11 were used for different concentrations of tested chemical 
compounds. The model of test plate was constructed by Ing. Jan Dubánek. 
Figure 3.4. The freshwater rotifer Brachionus calyciflorus. From 
Turchin (2003). 
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The toxicity test was carried out using polycarbonate multiwell test plates 
(with 43 wells). Under a dissection microscope at 10-fold magnification, rotifers 
were transferred first into the rinsing trough and then into the test wells. For a 
more detailed test schema see Figure 3.5.  
 
 
 
 
 
 
 
 
 
 
 
For each of the tested chemical compounds 15 concentrations of the 
respective toxicant were prepared. The concentrations started at 12 mg L-1 for the 
antibiotics and at 32 mg L-1 for potassium dichromate. 
Test plates were put in an incubator at 25 °C without illumination. Data 
(mortality of the rotifers) were collected after 24 hours of incubation. 
 
3.2.1.4. THAMNOTOXKIT F™ 
 
This test is intended as an acute toxicity determining test with a freshwater 
crustacean – Thamnocephalus platyurus (Figure 3.6.).  
As stated in the standard operational procedure, hatching of the cysts was 
performed 24 hours prior to the toxicity test. Polycarbonate multiwell test plates 
(with 24 test wells) were used for the toxicity test. After transferring from the 
hatching Petri dish into rinsing trough, the crustaceans were placed into the test 
Figure 3.5. The multiwell test plate used in the acute toxicity test with B. calyciflorus. Rows 
A and B, C and D, and E and F, respectively – replications of the determination, each containing 
300 µL of particular chemical compound solution and 5 experimental organisms. Columns 1 – 6 
were used for different concentrations of tested chemical compounds. Unnumbered horizontal 
wells served as rinsing trough. The long transversal well was intended as hatching well. The 
model of test plate was constructed by Ing. Jan Dubánek. 
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wells with effluent in the particular dilution. For a more detailed test schema see 
Figure 3.7. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
For each of the tested chemical compounds 9 concentrations of the 
respective toxicant were prepared. The concentrations started at 0.3 mg L-1 for the 
antibiotics and at 32 mg L-1 for potassium dichromate. 
Test plates were put into an incubator at 25 °C without illumination. Data 
(mortality of the crustaceans) were collected after 24 hours of incubation. 
 
 
 
Figure 3.6. The freshwater crustacean Thamnocephalus 
platyurus. From www.r-biopharm.com.  
Figure 3.7. The multiwell test plate used in the acute toxicity test with T. platyurus. Rows 
A and B, and C and D, respectively – duplications of the determination, each containing 300 µL 
of particular chemical compound solution and 10 experimental organisms. Columns 2 – 6 were 
used for different concentrations of tested chemical compounds. Wells of the column 1 served 
as rinsing trough. The model of test plate was constructed by Ing. Jan Dubánek. 
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3.2.2. Data Treatment 
 
All data were obtained in accordance either with the standard operational 
procedures of each toxicity test performed, or in compliance with respective 
method modifications. The time schedule of data gaining was also following 
either the instructions or the altered test procedure. 
The statistical processing of gained data (nonlinear regression) and the 
calculation of the commonly used ecotoxicological parameters for all toxicity tests 
conducted was performed by Mgr. Jitka Vytlačilová with the use of the statistical 
software GraphPad Prism (La Jolla, California, USA). 
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4. Results 
 
4.1. Acute Toxicity of Tested Quinolone Antibiotics on 
Pseudokirchneriella subcapitata 
 
Of all three fluoroquinolone antibiotics tested, ciprofloxacin and 
norfloxacin exhibited very similar acute toxicity on P. subcapitata (IC50 after 
72 hours slightly below 8 mg L-1), while ofloxacin was a little less toxic with the 
IC50 after 72 hours slightly above 9 mg L-1 (see Table 4.1.). The influence of 
ofloxacin on the growth rate rapidly decreased with increasing dilution of the 
tested antimicrobial agents (see Table 4.2. and Figure 4.1.). 
Overall, the acute toxicity of the antibiotics was 20-fold lower than the 
acute toxicity of the standard toxicant – potassium dichromate (IC50 after 72 hours 
0.40 mg L-1). 
 
  IC50,72h 
Ciprofloxacin 7.72 (7.17 – 8.317) 
Norfloxacin 7.99 (7.57 – 8.43) 
Ofloxacin 9.27 (8.81 – 9.77) 
 
 
  c1 c2 c3 c4 c5 c6 c7 c8 
w/v 12.00 6.00 3.00 1.50 0.75 0.38 0.19 0.09 
CIP 36.22 18.11 9.05 4.53 2.26 1.13 0.57 0.28 
NOR 27.12 13.56 6.78 3.39 1.70 0.85 0.42 0.21 
OFL 33.21 16.60 8.30 4.15 2.08 1.04 0.52 0.26 
 
 
 
Table 4.1. Pseudokirchneriella subcapitata acute toxicity test: IC50 values (mg L
-1) with 
confidence limits for each fluoroquinolone antibiotic. 
Table 4.2. Pseudokirchneriella subcapitata acute toxicity test: the used weight/volume and molar 
concentrations of fluoroquinolone antibiotics tested. w/v- weight/volume concentration of 
antibiotics (mg L-1), all other concentrations are molar (µmol L-1). CIP- ciprofloxacin, NOR- 
norfloxacin, OFL- ofloxacin. 
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4.2. Acute Toxicity of Tested Quinolone Antibiotics on 
Tetrahymnena  pyriformis 
 
 After 24 hours of treatment, the most toxic antimicrobial agent on T. 
pyriformis was ciprofloxacin (IC50 5.82 10-3 mg L-1), although both remaining 
fluoroquinolones exhibited high acute toxicity on the experimental organism (IC50 
slightly above 2 mg L-1 for norfloxacin and slightly above 1 mg L-1 for ofloxacin; 
see Table 4.3. and Figure 4.2.A). The IC50,24h value of the standard toxicant, 
potassium dichromate was 20.82 mg L-1 (17.27 – 25.11 mg L-1). 
 After 48 hours of treatment, the toxicity of tested antibiotics surprisingly 
changed, with norfloxacin as the most active in growth inhibition of T. pyriformis. 
The IC50 values of all three fluoroquinolones decreased at least one order of 
magnitude (to 10-4 mg L-1 for ciprofloxacin and ofloxacin, and to 10-5 mg L-1 for 
norfloxacin, respectively; see Table 4.3. and Figure 4.2.B). 
 This particular trend (i.e. the increase of growth inhibition after prolonged 
exposition to antibiotics and the highest toxicity switch between ciprofloxacin and 
norfloxacin) is noticeable throughout the whole concentration range of tested 
antibiotics (see Figure 4.2., Figure 4.3. and Table 4.4.). 
Figure 4.1. Pseudokirchneriella subcapitata acute toxicity test: the impact of antibiotics on the 
growth inhibition after 72 hours of treatment. The antibiotic concentrations decrease from c1 to 
c8. For the exact weight/volume and molar concentrations of the tested antibiotics see 
Table 4.2. CIP- ciprofloxacin, NOR- norfloxacin, OFL- ofloxacin. 
  43 
 
  IC50,24h IC50,48h 
Ciprofloxacin 5.82 10-3 (4.94 10-3 – 6.85 10-3) 1.15 10-4 (7.22 10-5 - 1.85 10-4) 
Norfloxacin 2.19 (1.82 – 2.64) 3.80 10-5 (1.61 10-5 - 8.99 10-5) 
Ofloxacin 1.08 (0.58 – 2.03) 2.35 10-4 (1,91 10-4 - 2.89 10-4) 
 
 
Table 4.3. Tetrahymena pyriformis acute toxicity test: IC50 values after 24 and 48 hours of 
treatment (mg L-1) with confidence limits for each fluoroquinolone antibiotic. 
Figure 4.2. Tetrahymena pyriformis acute toxicity test: the impact of antibiotics on the growth 
inhibition after A) 24 and B) 48 hours of treatment. The antibiotic concentrations decrease 
from c1 to c15. For the exact weight/volume and molar concentrations of the tested antibiotics 
see Table 4.4. CIP- ciprofloxacin, NOR- norfloxacin, OFL- ofloxacin. 
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  c1 c2 c3 c4 c5 c6 c7 c8 
w/v 3.0000 1.5000 0.7500 0.3750 0.1875 0.0938 0.0469 0.0234 
CIP 9054 4527 2264 1132 566 283 141 71 
NOR 6780 3390 1695 848 424 212 106 53 
OFL 8302 4151 2075 1038 519 259 130 65 
         
  c9 c10 c11 c12 c13 c14 c15  
w/v 0.0117 0.0059 0.0029 0.0015 0.0007 0.0004 0.0002  
CIP 35.37 17.68 8.84 4.42 2.21 1.11 0.55  
NOR 26.49 13.24 6.62 3.31 1.66 0.83 0.41  
OFL 32.43 16.21 8.11 4.05 2.03 1.01 0.51  
 
 
Table 4.4. Tetrahymena pyriformis acute toxicity test: the used weight/volume and molar 
concentrations of fluoroquinolone antibiotics tested. w/v- weight/volume concentration of 
antibiotics (mg L-1), all other concentrations are molar (nmol L-1). CIP- ciprofloxacin, NOR- 
norfloxacin, OFL- ofloxacin. 
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Figure 4.3. Tetrahymena pyriformis acute toxicity test: the impact of selected antibiotic 
concentrations on the growth inhibition. Concentrations: A) c1 B) c5 C) c10 D) c15. For the 
exact weight/volume and molar concentrations of the tested antibiotics see Table 4.4. CIP- 
ciprofloxacin, NOR- norfloxacin, OFL- ofloxacin. 
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4.3. Acute Toxicity of Tested Quinolone Antibiotics on 
Brachionus calyciflorus 
 
The acute toxicity of the tested antibiotics on B. calyciflorus after 24 hours 
treatment varied considerably: the highest acute toxicity was found for ofloxacin 
(LC50 was 6.05 10-4 mg L-1), while norfloxacin was significantly less toxic (LC50 
was slightly above 144 mg L-1) and the LC50 value for ciprofloxacin was 
somewhere in between (LC50 0.057 mg L-1; see Table 4.5.). In other words, 
norfloxacin slightly affected the mortality of the experimental organisms only 
when applied in the three highest concentrations, ciprofloxacin influenced the 
mortality in two thirds of the concentration range (i.e. c1 – c9), and ofloxacin 
impacted mortality of the crustaceans in the whole tested concentration range (see 
Figure 4.4. and Table 4.6.). 
The LD50 value of the standard toxicant, potassium dichromate, after 24 
hours of treatment was 13.70 mg L-1 (9.60 – 17.80 mg L-1). 
  LC50,24h 
Ciprofloxacin 5.74 10-2 (4.79 10-2 – 6.87 10-2) 
Norfloxacin 144.2 (78.04 – 266.6) 
Ofloxacin 6.05 10-4 (5.72 10-4 – 6.40 10-4) 
 
  c1 c2 c3 c4 c5 c6 c7 c8 
w/v 12.000 6.000 3.000 1.500 0.750 0.375 0.188 0.094 
CIP 36217 18108 9054 4527 2264 1132 566 283 
NOR 27122 13561 6780 3390 1695 848 424 212 
OFL 33207 16603 8302 4151 2075 1038 519 259 
         
  c9 c10 c11 c12 c13 c14 c15  
w/v 0.0469 0.0234 0.0117 0.0059 0.0029 0.0015 0.0007  
CIP 141.47 70.74 35.37 17.68 8.84 4.42 2.21  
NOR 105.94 52.97 26.49 13.24 6.62 3.31 1.66  
OFL 129.71 64.86 32.43 16.21 8.11 4.05 2.03  
 
 
 
 
Table 4.5. Brachionus calyciflorus acute toxicity test: LC50 values after 24 hours of treatment 
(mg L-1) with confidence limits for each fluoroquinolone antibiotic. 
Table 4.6. Brachionus calyciflorus acute toxicity test: the used weight/volume and molar 
concentrations of fluoroquinolone antibiotics tested. w/v- weight/volume concentration of 
antibiotics (mg L-1), all other concentrations are molar (nmol L-1). CIP- ciprofloxacin, NOR- 
norfloxacin, OFL- ofloxacin. 
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4.4. Acute Toxicity of Tested Quinolone Antibiotics on 
Thamnocephalus platyurus 
 
 In the concentration range of antibiotics used for the toxicity tests (see 
Table 4.7.), none of the three tested fluoroquinolones exhibited acute toxicity on 
T. platyurus. The mortality of experimental organisms was 10% or less (see 
Figure 4.5.), which is not sufficient to provide reliable results for statistical 
analysis and calculation of appropriate ecotoxicological parameters. 
 
 
 
 
  c1 c2 c3 c4 c5 c6 c7 c8 c9 
w/v 300.00 150.00 75.00 37.50 18.75 9.38 4.69 2.34 1.17 
CIP 905.41 452.71 22.35 113.18 56.59 28.29 14.15 7.07 3.54 
NOR 678.04 339.02 169.51 84.76 42.38 21.19 10.59 5.30 2.65 
OFL 830.17 415.09 207.54 103.77 51.89 25.94 12.97 6.49 3.24 
Figure 4.4. Brachionus calyciflorus acute toxicity test: the impact of antibiotics on the mortality 
of experimental organisms after 24 hours of treatment. The antibiotic concentrations decrease 
from c1 to c15. For the exact weight/volume and molar concentrations of the tested antibiotics 
see Table 4.6. CIP- ciprofloxacin, NOR- norfloxacin, OFL- ofloxacin. 
Table 4.7. Thamnocephalus platyurus acute toxicity test: the used weight/volume and molar 
concentrations of fluoroquinolone antibiotics tested. w/v- weight/volume concentration of 
antibiotics (µg L-1), all other concentrations are molar (nmol L-1). CIP- ciprofloxacin, NOR- 
norfloxacin, OFL- ofloxacin. 
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Figure 4.5. Thamnocephalus platyurus acute toxicity test: the impact of antibiotics on the 
mortality of experimental organisms after 24 hours of treatment. The antibiotic concentrations 
decrease from c1 to c9. For the exact weight/volume and molar concentrations of the tested 
antibiotics see Table 4.7. CIP- ciprofloxacin, NOR- norfloxacin, OFL- ofloxacin. 
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5. Discussion 
 
5.1. Discussion of Methods Used 
 
 During the presented research have arisen several issues with the optimal 
methods. Some of them are of great influence on the reliability and consistence of 
obtained results, and therefore there is large space for discussion on a deeper 
level. 
 
5.1.1. Changes in Standard Operational Procedure of 
ALGALTOXKITTM 
 
Data collected in this test was performed with the use of a light 
microscope and Bürker cell for manual cell counting (for details see 
Chapter 3.2.1.1.). This change of standard operational procedure was necessary 
due to the unavailability of the required equipment (a spectophotometer for 10 cm 
cells) and caused several inconveniences.  
First of all, the time frame of the test was heavily altered: while a 
spectrophotometric sample measurement takes about two minutes, the manual cell 
counting is more time-consuming (approximately 15 minutes for a single sample). 
For 10 samples, the difference is over two hours and for all 56 samples, the time 
schedule is shifted considerably (well over eight hours).  
Secondly, the abovementioned altered schedule could lead with high 
probability to unreliable results. To minimize this threat, control samples were 
measured in regular intervals and the cell numbers of samples treated with 
toxicants were corrected accordingly.  
However, the control samples were measured in two-hour intervals; that 
means that there is still possibility for the results to be underestimated and thus, 
the toxicity of the tested antibiotics may appear higher (i.e. the calculated IC50 
values will be lower). The best option how to eradicate this particular error is to 
perform the test with the spectrophotometric measurement. 
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5.1.2. Quinolone Antibiotics Concentrations in the Modified 
PROTOXKITTM 
 
 In the modified protozoan toxicity test the concentration of quinolones 
starts at 3 mg L-1. This inconvenience creating a slight discrepancy in the 
presented results was caused by an unpredictable behavior of the used 
experimental organism, Tetrahymena pyriformis.  
As of November 2009, there was an inadequate growth response of T. 
pyriformis in all conducted toxicity tests. Various modifications of the 
experimental conditions were unsuccessful and different batches of experimental 
organisms also failed to provide accurate results.  
Therefore, a new experimental organism, T. thermophila, is currently 
being tested, and the optimal experimental conditions are being adjusted. Thus, 
results published in this work represent the early conducted toxicological tests 
from before November 2009. 
 
5.2. The Impact of Quinolone Antibiotics on Selected 
Experimental Organisms 
 
 In this chapter, the influence of the three quinolone antibiotics on the 
tested organisms will be discussed. I tried to include only studies focused on 
quinolones and their effects on the same experimental organisms that were used in 
presented research, but due to lack of publications fulfilling these criteria, there 
are some works with different antibacterial agent and/or experimental organism 
included. The lack of ecotoxicological studies concerning (not exclusively) 
quinolones was marked for example by Christensen et al. (2009). 
 
5.2.1. The Effect of Quinolone Antibiotics on Freshwater Green 
Algae with the Emphasis on Pseudokirchneriella supcapitata 
 
Based of the collected data (see Chapter 4.1.), the algal species 
Pseudokirchneriella subcapitata seems to have similar tolerance to all three tested 
quinolones. The growth rate of the algae was inhibited only by antibiotic 
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concentrations around 8 mg L-1 (ciprofloxacin, norfloxacin) and over 9 mg L-1 
(ofloxacin; details in Chapter 4.1.).   
That norfloxacin is influencing the growth rate and photosynthetic 
parameters in green algae prevalently in higher concentrations, has been observed 
also by Eguchi et al. (2004). The authors found that norfloxacin concentrations 
under 4 mg L-1 did not affect algal cultures of two freshwater algae, 
P. subcapitata and Chlorella vulgaris. Only concentrations of norfloxacin 
exceeding 10 mg L-1 (for Pseudokirchneriella) and 14 mg L-1 (for Chlorella), 
respectively lead to a significant growth and photosynthetic rate decrease (Eguchi 
et al., 2004). 
Even higher tolerance of green algae (P. subcapitata and Scenedesmus 
obliquus) to quinolone antibiotic was reported by Robinson et al. (2005) and Nie 
et al. (2009). Robinson et al. (2005) provided research focused on the toxicity of 
seven fluoroquinolone antibiotics (including ciprofloxacin and ofloxacin) on 
selected aquatic organisms. The authors reported that to P. subcapitata, both 
ciprofloxacin (EC50,24h 18.7 mg L-1) and ofloxacin (EC50,24h 12.1 mg L-1) were the 
least toxic of all fluoroquinolones investigated (Robinson et al., 2005). Similar 
results were reported by Nie et al. (2009) who studied the influence of norfloxacin 
(in concentrations ranging from 3.75 to 60 mg L-1) on S. obliquus. A decrease in 
growth rate and the content of chlorophyll a were observed only when the algal 
culture was exposed to norfloxacin concentration exceeding 15 mg L-1 (Nie et al., 
2009).  
The finding, that ciprofloxacin seems to have similar toxicity levels as 
norfloxacin on green algae is supported by Nie et al. (2008) who observed growth 
rate inhibition of the green alga C. vulgaris only at ciprofloxacin concentrations 
higher than 12 mg L-1. 
The documented concentrations of quinolones in the environment are 
several orders of magnitude lower than the concentrations shown to cause growth 
inhibition – they vary in the rank of tens to hundreds of ng L-1 (see Chapter 
2.2.2.1.) – which suggests that even the raw sewage with the highest amount of 
quinolones present should not affect the algal population in surface waters.  
Furthermore, some of the algal genera (including Pseudokirchneriella and 
Scenedesmus) seem to have the ability of (at least partially) evolving into 
antibiotic-resistant species as shown by Sánchez-Fortún et al. (2009). The authors 
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tested the impact of one of the most used antibiotic agents utilized in aquaculture 
(namely chloramphenicol) on the growth rate and photosynthetic performance in 
Scenedesmus intermedius. After 72 hours of exposure chloramphenicol caused 
growth inhibition and decrease of photosynthesis; however, in the time span of 60 
days the algal culture restored both the growth and photosynthetic rate because of 
spontaneous mutation resulting in the evolution of chloramphenicol-resistant cells 
(Sánchez-Fortún et al., 2009).  
Similarly, Nie et al. (2009) also observed cell adaptability of S. obliquus 
culture to norfloxacin exposure in a longer time span in both growth rate and 
chlorophyll a content. And Eguchi et al. (2004) reported that norfloxacin strongly 
inhibited the growth rate of P. subcapicata early in the study (the first day), while 
later (the third day), the growth rate of the norfloxacin-treated culture even 
exceeded the growth rate of control population. None of other antimicrobial 
agents tested in their research (erythromycin, oxytetracycline, several 
sulfonamides, and selected β-lactam antimicrobials) had shown similar properties 
(Eguchi et al., 2004). 
To extrapolate the results of three studies (one with a chemically different 
compound, even) on the presented research would be inappropriate. On the other 
hand, at least it has been suggested that the algal genera Pseudokirchneriella and 
Scenedesmus might potentially gain adaptive mechanisms to antibiotic agents and 
therefore would probably not be endangered by low quinolone concentrations 
present in the environment.  
However, this may not be true for all algal species present in freshwater 
ecosystems (esp. the blue green algae; e.g. Robinson et al., 2005). Sanderson et al. 
(2004) provided a large research focused on the environmental risk assessment of 
several pharmacological groups of active substances to surface waters. In this 
study, the authors found that while antibacterial agents do not have a high 
potential to accumulate in biologic materials, they represent a significant threat to 
algal populations. There seems to be, however, only a restricted number of 
antibacterial agents with a high-level hazard quotient – about 10% of the whole 
amount of the therapeutically used antibacterial active compounds (Sanderson et 
al., 2004). 
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5.2.2. The Effects of Quinolone Antibiotics on the Ciliated 
Protozoan Tetrahymena pyriformis 
 
 The genus Tetrahymena, particularly species T. pyriformis as well as 
T. thermophila have been proved to be useful in ecotoxicological studies (a large 
review of the use and the studies conducted on T. pyriformis was provided by 
Suavant et a.l, 1999).  
According to available literary sources (Web of Knowledge) up to April 
2010 there are, however, no published works dealing at least marginally with the 
toxicity of quinolone antibiotics on this particular genus. Although Suavant et al. 
(1999) in their review remarked that “Many substances have been tested with 
Tetrahymena pyriformis. Most of them are antibiotics…” the authors listed 
exactly three works focusing on the antibiotic agents: Krawczynska (1990) 
studying the effect of polymyxin B and two aminoglycosidic antibiotics on the 
phagocytic activity of T. pyriformis, Nilsson (1989) dealing partially with 
chloramphenicol and Wu et al. (1996) characterizing membrane action of 
chloramphenicol with the use of T. pyriformis motility inhibition. As antibiotics 
represent a large, non-homogenous group with compounds of substantially 
different chemical structure and mechanism of action, it is probably not 
appropriate to equate the effect of the mentioned antibiotics to the impact of 
quinolones on the Tetrahymena genus. 
Further pursuit provided that such research was neither done with another 
frequently used protozoan genus, Paramecium. Most of the available studies 
focused on the effects of various heavy metals and herbicides on the both 
abovementioned protozoan genera (e.g. Miyoshi et al., 2003 focused on 
P. caudatum and P. trichium; Sauvant et al., 1999 dealing with T. pyriformis).  
For these reasons, there is actually not a single work I could discuss results 
obtained in the presented research. The actual results suggest that T. pyriformis 
reacts diversely when exposed to different fluoroquinolones (ciprofloxacin being 
the most toxic) and that the length of treatment may increase the sensitivity of the 
test organism to investigated antibiotics (considerably increased toxicity of 
norfloxacin after 48 hours of treatment; see Chapter 4.2.). The IC50,48h values for 
all investigated quinolones are furthermore in the range of the reported 
fluoroquinolone antibiotics concentrations in the environment (see 
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Chapter 2.2.2.1.), and thus they may have negative influence on the naturally 
occurring populations of various Tetrahymena species. 
  
5.2.3. The Effects of Quinolone Antibiotics on the Freshwater 
Rotifer Brachionus calyciflorus 
 
In ecotoxicological screenings, the species Brachionus plicatilis is 
probably more used experimental organism than Brachionus calyciflorus, which 
caused some problems, especially regarding the availability of published works 
focused on B. calyciflorus. As B. plicatilis is a brakish-water inhabitant, while 
B. calyciflorus represents a freshwater species, their natural ecosystems are 
substantially different. Furthermore, there are works that show a great variability 
in response of two different Brachionus species (or even different strains of one 
species) to exposure of antimicrobial agents (Araujo and McNair, 2007 and 
references therein).  
Overall, there are not many studies focused on toxicity tests on 
B. calyciflorus using quinolone antibiotics as toxicants (in fact, the only published 
research I managed to obtain was that of Isidori et al., 2005; see text bellow). 
 
The present results show that the acute toxicity of the quinolone antibiotics 
on the experimental organism is considerably different for each of the three 
fluoroquinolones (the LC50 values vary in the range of several orders of 
magnitude – from 10-4 to 102 mg L-1; see Chapter 4.3.) with ofloxacin being the 
most toxic, which is in contradiction with published studies. For example, the 
mentioned work of Isidori et al., (2005) reported LC50,24h for ofloxacin for 
B. calyciflorus slightly bellow 30 mg L-1, although the chronic toxicity of 
ofloxacin was higher (the value of LC50,48h was 0.53 mg L-1).  
The present results suggest that ofloxacin may have a negative impact on 
the naturally occurring populations of B. calyciflorus as the LC50 value for this 
fluoroquinolone antibiotic is in the range of quinolone concentrations reported in 
the environment (see Chapter 2.2.2.1.). 
Apart from the work of Isidori et al. (2005), there were, however, no 
studies I could discuss the obtained results with, as the only other research dealing 
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with the effect of the quinolone antibiotic ofloxacin focused on chronic toxicity 
rather than acute toxicity of ofloxacin on B. calyciflorus (Ferrari et al., 2003). 
 
5.2.4. The Effects of Quinolone Antibiotics on Freshwater 
Crustaceans Thamnocephalus platyurus and Daphnia magna 
 
According to available literal sources (Web of Knowledge) as of April 
2010, there are only two published works dealing with the effects of antimicrobial 
agents on the freshwater anostracan crustacean Thamnocephalus platyurus (Isidori 
et al., 2005, and Kim et al., 2009; see text bellow). There are, however, more 
studies acknowledging T. platyurus as a valuable experimental organism in the 
field of ecotoxicology and proving that results obtained in toxicity tests with this 
particular crustacean species are reliable and demonstrative in evaluating the 
toxicity of tested chemicals (e.g. Centeno et al., 1995; Manusadzianas et al., 2003; 
Torokne, 2004).  
 
T. platyurus was used as an experimental organism in a research by Kim et 
al. (2009) focused on a large number of chemically unrelated pharmaceuticals 
(e.g. several NSAIDs, β-blockers, antihistaminic and antipsychotic drugs, and 
among all, selected antimicrobial agents: macrolide antibiotics – clarithromycin 
and erythromycin, and quinolone antibiotic levofloxacin). While clarithromycin 
was found to be toxic at least in high concentrations (the 24-hour medial lethal 
concentration was slightly above 90 mg L-1), both erythromycin and levofloxacin 
did not exhibit any acute toxicity toward T. platyurus (Kim et al., 2009). 
In the present research, the whole range of antibiotic concentrations tested 
caused less than 10% mortality of experimental organisms (see Chapter 4.4.), 
suggesting that T. platyurus is not sensitive to the low concentrations of 
fluoroquinolones reported in the environment (see Chapter 2.2.2.1.) This finding 
is in accordance with the research of Isidori et al. (2005) who tested acute toxicity 
of six antibiotic agents (including ofloxacin) on T. platyurus. The authors reported 
that the LC50,24h concentration of ofloxacin on T. platyurus was slightly above 
30 mg L-1 (Isidori et al., 2005), which is a concentration 100-fold higher than the 
highest ofloxacin concentration used in the present research (see Chapter 3.2.1.4.) 
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and several orders of magnitude higher than the values of concentrations of 
quinolones reported in the environment (see Chapter 2.2.2.1.). 
 
Persoone et al. (1994) compared the sensitivity of T. platyurus with the 
more used cladoceran crustacean species Daphnia magna on different types of 
environmental samples (e.g. effluents, river sediments, and sludge) and pure 
chemicals. A similar research was performed ten years later by Torokne (2004) 
who compared the sensitivity of T. platyurus with D. magna on selected samples 
contaminated with different chemicals (e.g. insecticide phosdrin, acaricide 
chlordimeform, and heavy metals). The authors concluded that both experimental 
organisms show similar sensitivity to exposed toxicants (Persoone et al., 1994 and 
Torokne, 2004) and thus, it can be assumed that the sensitivity of the two species 
will be similar when exposed to antimicrobial agents.  
Park and Choi (2008) included a quinolone antibiotic, enrofloxacin, in 
their study on the effects of commonly used antibiotics on aquatic systems. The 
authors showed enrofloxacin to be toxic to D. magna in concentrations exceeding 
130 mg L-1 in the first 24 hours, however, the toxicity of enrofloxacin increased 
significantly in the next 24 hours (EC50 for 48 hours was 56.7 mg L-1).  
Similar results were provided by Kim et al. (2010), who in addition 
studied also the influence of pH values of the toxicants solutions, water 
temperature and UV B irradiance on the toxicity of tested antibiotics. The authors 
found that enrofloxacin had higher toxicity to D. magna at lower water pH values, 
but the absolute EC50 values at all three examined pH values were conformable to 
those of Park and Choi (2008) – EC50 for 24 hours was around 100 mg L-1 and 
EC50 for 48 hours was around 50 mg L-1 (Kim et al., 2010).  
These results suggest that while acute toxicity of enrofloxacin may be low 
(EC50 for the first 24 hours is several orders of magnitude higher than 
concentrations of quinolones reported in the environment; see Chapter 2.2.2.1.), 
there is the risk of chronic toxicity that may significantly influence crustacean 
populations in surface waters. Similar findings were reported by Yamashita et al. 
(2006) for levofloxacin. The authors observed no acute toxicity of levofloxacin on 
D. magna, although levofloxacin did exhibit chronic toxicity on this crustacean 
species (Yamashita et al., 2006). 
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On the other hand, the toxicity of enrofloxacin significantly decreased 
when the antibiotic was exposed to UV B radiance (Kim et al., 2010), which 
confirms the accuracy of a photodegradation step in treatment of (especially 
hospital) wastewaters containing quinolones (Berto et al., 2009; Sirtori et al., 
2009a, b). 
 
Ciprofloxacin seems to be problematic regarding its toxic properties on 
D. magna: while Kim et al. (2010) reported the ciprofloxacin EC50 for 48 hours 
slightly above 1 mg L-1 (which suggests high acute toxicity), Robinson et al. 
(2005) in their study of seven quinolone antibiotics concluded that none of them 
(ciprofloxacin included) exhibits acute toxicity on D. magna. The results of 
present research (see Chapter 4.4.) can, however, not fully confirm the findings of 
either Robinson et al. (2005) or those of Kim et al. (2010) as the investigated 
antibiotic concentrations were lower than those used in both mentioned studies. 
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Conclusions 
 
• In order to obtain relevant acute toxicity data, the concentrations of 
investigated fluoroquinolone antibiotics started at values several orders of 
magnitude higher (mg L-1) than the documented values of fluoroquinolone 
antibiotics in the environment (ng L-1). 
• The acute toxicity of investigated fluoroquinolone antibiotics varied 
among the test species. Low acute toxicity of quinolone antibiotics was 
found for P. subcapitata and T. platyurus. High acute toxicity of the 
antimicrobials was reported for B. calyciflorus (with the exception of 
norfloxacin) and T. pyriformis.  
• The obtained acute toxicity data of the investigated fluoroquinolones are 
mainly in accordance with available literal sources. There is, however, a 
lack of published studies dealing with the ecotoxicological screening of 
fluoroquinolones. 
• Based on the obtained data and with regard to reported values of 
fluoroquinolone concentrations in the environment, all three investigated 
quinolones may have a negative impact on the population of T. pyriformis 
and ofloxacin may negatively influence the population of B. calyciflorus.  
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